Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuhui Chen

Showing results (91-100 of 112) with videos related to

Pageof 12
Sort By:
Bioorganic & Medicinal Chemistry Letters|April 24, 2017
Discovery and optimization of selective FGFR4 inhibitors via scaffold hoppingYikai Wang, Zhengxia Chen, Meibi Dai, et al.
ACS Medicinal Chemistry Letters|February 20, 2018
Discovery of 3,3'-Spiro[Azetidine]-2-oxo-indoline Derivatives as Fusion Inhibitors for Treatment of RSV InfectionWeihua Shi, Zhigan Jiang, Haiying He, et al.
Bioorganic & Medicinal Chemistry Letters|October 18, 2017
Discovery of aminocyclohexene analogues as selective and orally bioavailable hNav1.7 inhibitors for analgesiaMingxing Teng, Wentao Wu, Zhixiang Li, et al.
ACS Medicinal Chemistry Letters|April 20, 2018
Correction to "The Discovery of 3,3'-Spiro[azetidine]-2-oxo-indoline Derivatives as Fusion Inhibitors for Treatment of RSV Infection"Weihua Shi, Zhigan Jiang, Haiying He, et al.
Bioorganic & Medicinal Chemistry Letters|October 9, 2020
Design, syntheses and evaluations of novel indole derivatives as orally selective estrogen receptor degraders (SERD)Jiaqiang Dong, Tie-Lin Wang, Jianyu Lu, et al.
Bioorganic & Medicinal Chemistry Letters|May 27, 2015
Michael acceptor in gambogic acid--Its role and application for potent antitumor agentsJing Wang, Wang Shen, Zhiliang Yuan, et al.
Science Advances|July 4, 2025
Integrated in vivo functional screens and multiomics analyses identify α-2,3-sialylation as essential for melanoma maintenancePraveen Agrawal, Shuhui Chen, Ana de Pablos, et al.
ACS Medicinal Chemistry Letters|July 18, 2019
Discovery of a Novel Selective Dual Peroxisome Proliferator-Activated Receptor α/δ Agonist for the Treatment of Primary Biliary CirrhosisZhigan Jiang, Xing Liu, Zhiliang Yuan, et al.
Bioorganic & Medicinal Chemistry Letters|April 14, 2022
Discovery and preclinical evaluations of WX-0593, a novel ALK inhibitor targeting crizotinib-resistant mutationsXile Liu, Lu Zhang, Haiwen Wan, et al.
Antimicrobial Agents and Chemotherapy|July 29, 2020
Therapeutic Effect and Mechanisms of the Novel Monosulfactam 0073Ying Sun, Xueyuan Liao, Zhigang Huang, et al.
Pageof 12

Showing results (91-100 of 112) with videos related to

Sort By:
Pageof 12
Bioorganic & Medicinal Chemistry Letters|April 24, 2017
Discovery and optimization of selective FGFR4 inhibitors via scaffold hoppingYikai Wang, Zhengxia Chen, Meibi Dai, et al.
ACS Medicinal Chemistry Letters|February 20, 2018
Discovery of 3,3'-Spiro[Azetidine]-2-oxo-indoline Derivatives as Fusion Inhibitors for Treatment of RSV InfectionWeihua Shi, Zhigan Jiang, Haiying He, et al.
Bioorganic & Medicinal Chemistry Letters|October 18, 2017
Discovery of aminocyclohexene analogues as selective and orally bioavailable hNav1.7 inhibitors for analgesiaMingxing Teng, Wentao Wu, Zhixiang Li, et al.
ACS Medicinal Chemistry Letters|April 20, 2018
Correction to "The Discovery of 3,3'-Spiro[azetidine]-2-oxo-indoline Derivatives as Fusion Inhibitors for Treatment of RSV Infection"Weihua Shi, Zhigan Jiang, Haiying He, et al.
Bioorganic & Medicinal Chemistry Letters|October 9, 2020
Design, syntheses and evaluations of novel indole derivatives as orally selective estrogen receptor degraders (SERD)Jiaqiang Dong, Tie-Lin Wang, Jianyu Lu, et al.
Bioorganic & Medicinal Chemistry Letters|May 27, 2015
Michael acceptor in gambogic acid--Its role and application for potent antitumor agentsJing Wang, Wang Shen, Zhiliang Yuan, et al.
Science Advances|July 4, 2025
Integrated in vivo functional screens and multiomics analyses identify α-2,3-sialylation as essential for melanoma maintenancePraveen Agrawal, Shuhui Chen, Ana de Pablos, et al.
ACS Medicinal Chemistry Letters|July 18, 2019
Discovery of a Novel Selective Dual Peroxisome Proliferator-Activated Receptor α/δ Agonist for the Treatment of Primary Biliary CirrhosisZhigan Jiang, Xing Liu, Zhiliang Yuan, et al.
Bioorganic & Medicinal Chemistry Letters|April 14, 2022
Discovery and preclinical evaluations of WX-0593, a novel ALK inhibitor targeting crizotinib-resistant mutationsXile Liu, Lu Zhang, Haiwen Wan, et al.
Antimicrobial Agents and Chemotherapy|July 29, 2020
Therapeutic Effect and Mechanisms of the Novel Monosulfactam 0073Ying Sun, Xueyuan Liao, Zhigang Huang, et al.
Pageof 12